Phase 1 Rare Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults between the ages of 40 and 80 (men or women) who have been diagnosed with possible or probable Multiple System Atrophy, Pure Autonomic Failure, or Parkinson's disease, based on recognized medical guidelines.
- People who experience a significant drop in blood pressure when standing up (a condition called neurogenic orthostatic hypotension), confirmed by specialized testing that shows the nervous system is not properly controlling blood pressure.
- People who are able and willing to give their informed consent to take part in the study.
Who may not be able to join:
- People who have high blood pressure while lying down (a reading of 160 mmHg or higher on two separate occasions).
- People who are pregnant.
- People who have a condition known to damage the nerves that control body functions, such as diabetes, amyloidosis, certain blood protein disorders, or autoimmune nerve conditions.
- People who have a known aortic aneurysm, or who have had chest, abdominal, or pelvic surgery in the past 6 months.
- People who have hernias in the abdomen or groin that are causing symptoms.
- People who have severe acid reflux (heartburn).
- People with recent broken or cracked ribs or fractures in the spine.
- People who have a medical device on or inside the abdomen that could interfere with abdominal compression.
- People who cannot tolerate any increase in pressure in the abdomen.
- People with unstable heart disease, or who have had a major heart or neurological event in the past 6 months, or who have other health or mental health concerns that the trial team believes would prevent them from completing the study (confirm with trial site).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Italo Biaggioni, MD, Vanderbilt University Medical Center
Phone: 615-343-6862
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Stroke volume
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.